Tonix Pharmaceuticals Holding Share Price Today
(NASDAQ: TNXP)

Name: Tonix Pharmaceuticals Holding Share Price Today (NASDAQ: TNXP) - Tonix Pharmaceuticals Holding Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Tonix Pharmaceuticals Holding share price is $15 & ₹1,303.92 as on 15 Mar 2025, 2.30 'hrs' IST

$15

▲

1.36

(9.97%)

Market is closed - opens 7 PM, 17 Mar 2025

View live Tonix Pharmaceuticals Holding share price in Dollar and Rupees. Guide to invest in Tonix Pharmaceuticals Holding stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tonix Pharmaceuticals Holding, along with analyst recommendations, forecasts, and comprehensive financials.

Tonix Pharmaceuticals Holding share price movements

Today's Low: $13.54
Today's High: $15.67
$15.00
9.71%
Downside
Day's Volatility :13.57%
Upside
4.28%
52 Weeks Low: $6.76
52 Weeks High: $1,193.28
$15.00
54.93%
Downside
52 Weeks Volatility :99.43%
Upside
98.74%

Tonix Pharmaceuticals Holding (TNXP) Returns

Period	Tonix Pharmaceuticals Holding Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-71.7%	4.0%	0.0%
6 Months	1.69%	-7.8%	0.0%
1 Year	-98.59%	-0.3%	0.0%
3 Years	-99.99%	8.1%	-12.9%

Tonix Pharmaceuticals Holding (TNXP) Key Statistics

in dollars & INR

Previous Close	$13.64
Open	$13.5
Today's High	$15.67
Today's Low	$13.5431
Market Capitalization	$76.3M
Today's Volume	$976.4K
52 Week High	$1193.28
52 Week Low	$6.76
Revenue TTM	$11.3M
EBITDA	$-78.6M
Earnings Per Share (EPS)	$-8039.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-138.69%

How to invest in Tonix Pharmaceuticals Holding Stock (TNXP) from India?

It is very easy for Indian residents to invest directly in Tonix Pharmaceuticals Holding from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tonix Pharmaceuticals Holding stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tonix Pharmaceuticals Holding or TNXP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tonix Pharmaceuticals Holding or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tonix Pharmaceuticals Holding shares which would translate to 0.058 fractional shares of Tonix Pharmaceuticals Holding as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tonix Pharmaceuticals Holding, in just a few clicks!

Returns in Tonix Pharmaceuticals Holding (TNXP) for Indian investors in Rupees

The Tonix Pharmaceuticals Holding stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Tonix Pharmaceuticals Holding investment value today

Current value as on today

₹6,335

Returns

₹93,665

(-93.66%)

Returns from Tonix Pharmaceuticals Holding Stock

₹98,594 (-98.59%)

Dollar Returns

₹4,930 (+4.93%)

Indian investors sentiment towards Tonix Pharmaceuticals Holding (TNXP)

-76.67%

Period: Feb 14, 2025 to Mar 16, 2025. Change in 30 Days versus previous period

Investment in Tonix Pharmaceuticals Holding Shares from India has dropped by -76.67% over the past 30 days, indicating reduced transactional activity.

-59%

Period: Feb 14, 2025 to Mar 16, 2025. Change in 30 Days versus previous period

Search interest for Tonix Pharmaceuticals Holding Stock from India on INDmoney has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Tonix Pharmaceuticals Holding

Analyst Recommendation on Tonix Pharmaceuticals Holding

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Tonix Pharmaceuticals Holding(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Tonix Pharmaceuticals Holding Stock (TNXP)

What analysts predicted

Upside of 3344.44%

Target:

$516.67

Current:

$15.00

Insights on Tonix Pharmaceuticals Holding Stock (Ticker Symbol: TNXP)

Price Movement
In the last 7 days, TNXP stock has moved up by 15.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.20M → 2.82M (in $), with an average increase of 21.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -78.77M → -14.21M (in $), with an average increase of 454.3% per quarter
TNXP vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.0% return, outperforming this stock by 160.5%
TNXP vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 52.1% return, outperforming this stock by 152.1%
Price to Sales
ForTNXP every $1 of sales, investors are willing to pay $0.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.7 for every $1 of sales.

Tonix Pharmaceuticals Holding Technicals Summary

Sell

Neutral

Buy

Tonix Pharmaceuticals Holding is currently in a neutral trading position according to technical analysis indicators.

Tonix Pharmaceuticals Holding (TNXP) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tonix Pharmaceuticals Holding Corp.	25.52%	1.69%	-98.59%	-99.99%	-100.0%
Regeneron Pharmaceuticals, Inc.	-1.0%	-42.17%	-30.53%	-2.78%	37.5%
Beone Medicines Ltd	12.27%	31.94%	53.82%	34.32%	66.22%
Vertex Pharmaceuticals Incorporated	9.97%	3.13%	22.7%	102.65%	137.0%
Alnylam Pharmaceuticals, Inc.	-5.73%	-10.58%	64.01%	46.3%	133.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tonix Pharmaceuticals Holding Corp.	NA	NA	0.0	0.0	-1.39	-0.44	NA	47.68
Regeneron Pharmaceuticals, Inc.	17.76	17.76	1.01	42.83	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.4	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.52	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tonix Pharmaceuticals Holding Corp.	Buy	$76.3M	-100.0%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.4B	37.5%	17.76	31.07%
Beone Medicines Ltd	NA	$28.6B	66.22%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$129.1B	137.0%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.3B	133.04%	NA	-12.37%

About Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as rare disease, immunology, and infectious disease product candidates. The company's priority is to submit a New Drug Application (NDA) to the FDA for TNX-102 SL (cyclobenzaprine HCl sublingual tablet), which has completed two positive Phase 3 studies for the management of fibromyalgia. TNX-102 SL is also being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition. Its TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted breakthrough therapy designation by the FDA. The company's rare disease development portfolio comprises TNX-2900, an intranasal potentiated oxytocin for the treatment of Prader-Willi syndrome (PWS). Its immunology portfolio includes TNX-1500, which is a biologic to address organ transplant rejection and autoimmune diseases. The company's infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800 and TNX-1850, in development as a vaccine to protect against COVID-19. Its infectious disease development portfolio also comprises TNX-3900, and TNX-4200 are orally available CD45 antagonists in preclinical development. Tonix Pharmaceuticals Holding Corp. has collaboration agreement with Bilthoven Biologicals to advance TNX-801 mpox vaccine candidate; and with X-Chem, Inc. to develop broad-spectrum antivirals. The company was founded in 2007 and is headquartered in Chatham, New Jersey.

Organization	Tonix Pharmaceuticals Holding
Employees	103
CEO	Dr. Seth Lederman M.D.
Industry	Health Technology

Management People of Tonix Pharmaceuticals Holding

Name	Title
Dr. Seth Lederman M.D.	Co-Founder, President, CEO & Chairman
Mr. Bradley Saenger CPA	CFO & Treasurer
Mrs. Jessica Edgar Morris	Chief Operating Officer
Dr. Gregory M. Sullivan M.D.	Chief Medical Officer & Secretary
Ms. Siobhan Fogarty B.Sc., M.Sc.	Chief Technical Officer
Dr. Darryl Rideout Ph.D.	Executive Vice President of Experimental Chemistry
Dr. Sina Bavari Ph.D.	Executive Vice President of Infectious Disease Research & Development
Dr. Zeil Rosenberg M.D., M.P.H.	Executive Vice President of Medical
Mr. Thomas Englese	Executive Vice President of Commercial Operations

Important FAQs about investing in TNXP Stock from India :

What is Tonix Pharmaceuticals Holding share price today?

Tonix Pharmaceuticals Holding share price today stands at $15.00, Open: $13.50 ; Previous Close: $13.64 ; High: $15.67 ; Low: $13.54 ; 52 Week High: $1,193.28 ; 52 Week Low: $6.76.

The stock opens at $13.50, after a previous close of $13.64. The stock reached a daily high of $15.67 and a low of $13.54, with a 52-week high of $1,193.28 and a 52-week low of $6.76.

Can Indians buy Tonix Pharmaceuticals Holding shares?

Yes, Indians can invest in the Tonix Pharmaceuticals Holding (TNXP) from India.

With INDmoney, you can buy Tonix Pharmaceuticals Holding at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Tonix Pharmaceuticals Holding at zero transaction cost.

How can I buy Tonix Pharmaceuticals Holding shares from India?

It is very easy to buy Tonix Pharmaceuticals Holding from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tonix Pharmaceuticals Holding (TNXP) be purchased?

Yes, you can buy fractional shares of Tonix Pharmaceuticals Holding with INDmoney app.

What are the documents required to start investing in Tonix Pharmaceuticals Holding stocks?

To start investing in Tonix Pharmaceuticals Holding, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.